1. • Razavi-Shearer D, Gamkrelidze I, Pan C, Jia J, Berg T, Gray R, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet GastroenterolHepatol [Internet]. 2023 Jul 27 [cited 2023 Aug 9]; Available from: https://www.sciencedirect.com/science/article/pii/S2468125323001978. This provides estimates of country, regional, and global prevalence of hepatitis B virus infection in 2022 and the effects of treatment and prevention on disease burden.
2. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030 [Internet]. [cited 2023 Aug 7]. Available from: https://www.who.int/publications-detail-redirect/9789240053779
3. Global hepatitis report, 2017 [Internet]. [cited 2022 Jun 22]. Available from: https://www-who-int.libproxy2.usc.edu/publications-detail-redirect/9789241565455
4. Lan Y, Wang H, Weng H, Xu X, Yu X, Tu H, et al. The burden of liver cirrhosis and underlying etiologies: results from the Global Burden of Disease Study 2019. Hepatol Commun. 2023;7(2):e0026.
5. Choi S, Kim BK, Yon DK, Lee SW, Lee HG, Chang HH, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: a DALY-based analysis of the Global Burden of Disease 2019 study. Clin Mol Hepatol. 2023;29(2):433–52.